Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes
The dose-dependency of the effects of the alpha-glucosidase inhibitor Miglitol (Bay m 1099) was investigated in 8 Type II diabetic patients. Administration of increasing doses of Miglitol once daily in the morning on four consecutive days concomitantly with a standardized meal containing 50 g starch...
Saved in:
Published in | European journal of clinical pharmacology Vol. 37; no. 1; p. 33 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
1989
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The dose-dependency of the effects of the alpha-glucosidase inhibitor Miglitol (Bay m 1099) was investigated in 8 Type II diabetic patients. Administration of increasing doses of Miglitol once daily in the morning on four consecutive days concomitantly with a standardized meal containing 50 g starch led to a dose-dependent reduction in the maximal increase in the postprandial blood glucose level and in postprandial incremental AUC of blood glucose. The latter was significant for 50, 100, 75 and 200 mg Miglitol. Bay m 1099 also markedly retarded the appearance of the peak postprandial blood glucose concentration, which indicates delayed carbohydrate absorption. Serum insulin levels, documented as incremental AUCs of the serum insulin excursions, were not reduced dose dependently, because of the impaired insulin secretory capacity of the patients. |
---|---|
AbstractList | The dose-dependency of the effects of the alpha-glucosidase inhibitor Miglitol (Bay m 1099) was investigated in 8 Type II diabetic patients. Administration of increasing doses of Miglitol once daily in the morning on four consecutive days concomitantly with a standardized meal containing 50 g starch led to a dose-dependent reduction in the maximal increase in the postprandial blood glucose level and in postprandial incremental AUC of blood glucose. The latter was significant for 50, 100, 75 and 200 mg Miglitol. Bay m 1099 also markedly retarded the appearance of the peak postprandial blood glucose concentration, which indicates delayed carbohydrate absorption. Serum insulin levels, documented as incremental AUCs of the serum insulin excursions, were not reduced dose dependently, because of the impaired insulin secretory capacity of the patients. |
Author | Waldhäusl, W Komjati, M Korn, A Heinz, G |
Author_xml | – sequence: 1 givenname: G surname: Heinz fullname: Heinz, G organization: Department of Medicine I, University of Vienna, Austria – sequence: 2 givenname: M surname: Komjati fullname: Komjati, M – sequence: 3 givenname: A surname: Korn fullname: Korn, A – sequence: 4 givenname: W surname: Waldhäusl fullname: Waldhäusl, W |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2687007$$D View this record in MEDLINE/PubMed |
BookMark | eNotjzFvwjAUhD1QUaBduld6YzukfXYgjkdApUWiqlS1Qyfk-DngysRRYgb-PZZgutPd6ZNuzAZNaCxjDxxfOKJ8XawQC1RTgQM2Qsx5ViiJt2zc9_-IfKYwH7KhKEqZ1iMWvy0dTXShgVBDG_rYdrohpz1UPgSCnT-a0FuoThD3FrRv9zq7hI50Klyzd5WLoYNPt_PJeHhazP_gAByVek49xFNrYb2GhK1stP0du6m17-39VSfsd_X2s_zINl_v6-V8k5l8KmJGVFJNskRDNS8STQiyRMrSTJOuS5mkJKT0SRhltMzzQnPK5YxbU06tmLDHC7c9VgdL27ZzB92dttf34gw06VvR |
CitedBy_id | crossref_primary_10_1002_rcm_2822 crossref_primary_10_1016_j_jtumed_2016_03_006 crossref_primary_10_1016_j_apsb_2022_05_020 crossref_primary_10_2165_00003495_200059030_00012 crossref_primary_10_1016_S0168_8227_00_00231_X crossref_primary_10_1002_mnfr_201300599 crossref_primary_10_1046_j_1463_1326_2001_00141_x crossref_primary_10_1002_ceat_201100685 crossref_primary_10_2337_diacare_24_6_989 crossref_primary_10_1016_S0306_3623_97_00029_3 crossref_primary_10_1038_s41387_021_00152_5 crossref_primary_10_1345_aph_19269 crossref_primary_10_1007_s40268_014_0055_7 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1007/BF00609420 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 2687007 |
Genre | Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 476 53G 5QI 5RE 5VS 67N 67Z 6NX 6PF 78A 7RV 7X7 88E 8AO 8FI 8FJ 8FW 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQLM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYOK AAYQN AAYTO ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADOAH ADOJX ADRFC ADTPH ADURQ ADYFF ADYOE ADYPR ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS ECM ECT EIF EIHBH EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- MK0 N2Q N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 WOW Y6R YLTOR Z45 Z7U Z7V Z7W Z81 Z82 Z83 Z87 Z8O Z8P Z8Q Z8U Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM |
ID | FETCH-LOGICAL-c342t-dd8dfd780cdf1610922dedd9ed5adaf875ad8d0d5902c9ca7336a1d3751ec84e2 |
ISSN | 0031-6970 |
IngestDate | Sat Sep 28 08:33:59 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c342t-dd8dfd780cdf1610922dedd9ed5adaf875ad8d0d5902c9ca7336a1d3751ec84e2 |
PMID | 2687007 |
ParticipantIDs | pubmed_primary_2687007 |
PublicationCentury | 1900 |
PublicationDate | 1989-00-00 |
PublicationDateYYYYMMDD | 1989-01-01 |
PublicationDate_xml | – year: 1989 text: 1989-00-00 |
PublicationDecade | 1980 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | European journal of clinical pharmacology |
PublicationTitleAlternate | Eur J Clin Pharmacol |
PublicationYear | 1989 |
SSID | ssj0015903 |
Score | 1.4379061 |
Snippet | The dose-dependency of the effects of the alpha-glucosidase inhibitor Miglitol (Bay m 1099) was investigated in 8 Type II diabetic patients. Administration of... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 33 |
SubjectTerms | 1-Deoxynojirimycin - analogs & derivatives Adult Aged Blood Glucose - metabolism Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diet Dose-Response Relationship, Drug Glucosamine - adverse effects Glucosamine - analogs & derivatives Glucosamine - therapeutic use Glycoside Hydrolase Inhibitors Humans Imino Pyranoses Insulin - blood Middle Aged Time Factors |
Title | Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2687007 |
Volume | 37 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6lIKReKl4VUEBzQBXINbIdx14fCwIloFYVSqVyqtb7oEaJbTXuofwP_i-zD6_TliLgYkXeyEr2-zw7MzvzLSGv8pjnmaBRWESlCtNYiRBXQRqmieQZxwWNW7XPw2x6nH46mZyMRj_XqpYuuvIt__HbvpL_QRXvIa66S_YfkPUPxRv4GfHFKyKM17_C-IvWXe1dvrZZde257lLBWTf16EFfj65dTKSD6at1ReqVwOUrqOqzqsR3-jw4qL6hQ94stMf5bv9rsAz0ZpbOGehCSJ2nnc18ovbWdL5zbX27ZTsIY_vU_VRWtcla-1O9PjfL78yWFRwM92yV8ZBGYAtxZrb104vVwpcG2oyFLcnyGQtnhcdxmBX2wJDeClvplytssybV6mTcsPRRX78eZRihmoa6bg3ydmkwTzK0R_ZY3T8OXtPcdiMbZCOn2mwe6hSQ25qaFJFTcrZ_4qrmrfs1m-See8a1cMW4LfP7ZMvFG7BvyfOAjGT9kOweWVwu92A-9N-t9mAXjtYQe0Q6zzBoFKwzDAzDwDEMyktAhsENhoFnGPQMg9fIL1iC5tcbHAfNLpjNoGfXY3L88cP8_TR053SEfJwmXSgEFUrkNOJCxVq-P0mEFKKQYsIEUxgRM_xGJLRSEC840wqcLBbjfBJLTlOZbJM7dVPLJwQwGBGUjlUq0LXHSJ5xWrCSJ2gzpEqL7CnZtrN52loxllM3zc9uG9ghmwMHn5O7Ct99-QIdya58aYD9Baknclc |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduction+of+postprandial+blood+glucose+by+the+alpha-glucosidase+inhibitor+Miglitol+%28BAY+m+1099%29+in+type+II+diabetes&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Heinz%2C+G&rft.au=Komjati%2C+M&rft.au=Korn%2C+A&rft.au=Waldh%C3%A4usl%2C+W&rft.date=1989-01-01&rft.issn=0031-6970&rft.volume=37&rft.issue=1&rft.spage=33&rft_id=info:doi/10.1007%2FBF00609420&rft_id=info%3Apmid%2F2687007&rft_id=info%3Apmid%2F2687007&rft.externalDocID=2687007 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon |